Recombinant Human IgG1 Fc Protein, Active
Beta LifeScience
SKU/CAT #: BLK-01975P-100UG

Human IgG1 Fc on Tris-Bis PAGE under reduced condition. The purity is greater than 95%.
Recombinant Human IgG1 Fc Protein, Active
Beta LifeScience
SKU/CAT #: BLK-01975P-100UG
Collections: High-quality recombinant proteins
Our products are highly customizable to meet your specific needs. You can choose options such as endotoxin removal, liquid or lyophilized forms, preferred tags, and the desired functional sequence range for proteins. Submitting a written inquiry expedites the quoting process.
Product Overview
Description | Recombinant Human IgG1 Fc is expressed from HEK293 without tag.It contains Asp104-Lys330. |
Purity | > 95% as determined by Tris-Bis PAGE;> 95% as determined by HPLC |
Accession | P01857 |
Target Symbol | IgG1 Fc |
Synonyms | IgG1; Igh-4; RGD1359539; VH7183 |
Species | Human |
Expression System | HEK293 |
Tag | No Tag |
Expression Range | Asp104-Lys330 |
Mol. Weight | The protein has a predicted MW of 25.5 kDa. Due to glycosylation, the protein migrates to 31-33 kDa based on Tris-Bis PAGE result. |
Form | Lyophilized |
Formulation | Lyophilized from 0.22um filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization. |
Endotoxin | Less than 1EU per ug by the LAL method. |
Activity | The affinity constant of 0.28 uM as determined in SPR assay (Biacore T200). Contact us for detailed testing images. |
Storage | Reconstituted protein stable at -80°C for 12 months, 4°C for 1 week. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. |
Shipping | Shipped at ambient temperature. |
Gene Background | IgG1 is most abundant in serum among the four IgG subclasses (IgG1, 2, 3 and 4) and binds to Fc receptors (FcγR) on phagocytic cells with high affinity. Fc fragment is demonstrated to mediate phagocytosis, trigger inflammation, and target Ig to particular tissues.IgG1 Fc was reported has a novel role as a potential anti-inflammatory drug for treatment of human autoimmune diseases. |